1. Home
  2. SNX vs BIO Comparison

SNX vs BIO Comparison

Compare SNX & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TD SYNNEX Corporation

SNX

TD SYNNEX Corporation

HOLD

Current Price

$154.22

Market Cap

12.6B

Sector

Technology

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$302.70

Market Cap

8.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNX
BIO
Founded
1980
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
12.6B
8.2B
IPO Year
2003
N/A

Fundamental Metrics

Financial Performance
Metric
SNX
BIO
Price
$154.22
$302.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
4
Target Price
$168.60
$358.50
AVG Volume (30 Days)
746.8K
158.3K
Earning Date
01-08-2026
02-12-2026
Dividend Yield
1.15%
N/A
EPS Growth
18.98
N/A
EPS
9.21
N/A
Revenue
$60,973,509,000.00
$2,557,500,000.00
Revenue This Year
$7.25
$1.62
Revenue Next Year
$4.35
$2.26
P/E Ratio
$16.63
N/A
Revenue Growth
6.94
N/A
52 Week Low
$92.23
$211.43
52 Week High
$167.76
$373.69

Technical Indicators

Market Signals
Indicator
SNX
BIO
Relative Strength Index (RSI) 51.29 42.26
Support Level $151.56 $295.01
Resistance Level $155.82 $307.07
Average True Range (ATR) 3.28 8.09
MACD -0.03 -1.25
Stochastic Oscillator 49.73 22.23

Price Performance

Historical Comparison
SNX
BIO

About SNX TD SYNNEX Corporation

TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: